Straight talk with… Mark Sculpher

Nature Medicine, 7 September 2012
www.nature.com/nm/journal/v18/n9/full/nm0912-1315.html

By 2014, the UK will be changing the way it regulates the price it pays for medicines. The government has embraced an idea known as value-based pricing (VBP), with negotiations on how the system will work due to begin this month. One of the most influential thinkers on the UK’s proposed system is health economist Mark Sculpher, director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York. Kate Ravilious met with Sculpher to discuss the value of VBP.

READ ARTICLE AT Nature Medicine